CFM
MRVI icon

Capricorn Fund Managers’s Maravai LifeSciences MRVI Stock Holding History

Capricorn Fund Managers’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$961K Buy
+339,727
New +$1.15M 0.15% 91

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capricorn Fund Managers's MRVI Position: Q1 2026 in Review

Capricorn Fund Managers opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 339,727 shares worth $961K. The stake represents 0.15% of the portfolio and ranks #91 among its holdings.

158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Capricorn Fund Managers held 339,727 shares of Maravai LifeSciences worth $961K as of Q1 2026.
  • Maravai LifeSciences was a new Capricorn Fund Managers position in Q1 2026.
  • Maravai LifeSciences made up 0.15% of Capricorn Fund Managers's portfolio in Q1 2026, its #91 holding.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Capricorn Fund Managers's 13F filing for Q1 2026, filed 24 Apr 2026.